Involvement of CUL4A in Regulation of Multidrug Resistance to P-gp Substrate Drugs in Breast Cancer Cells

Abstract

CUL4A encodes a core component of a cullin-based E3 ubiquitin ligase complex that regulates many critical processes such as cell cycle progression, DNA replication, DNA repair and chromatin remodeling by targeting a variety of proteins for ubiquitination and degradation. In the research described in this report we aimed to clarify whether CUL4A participates in multiple drug resistance (MDR) in breast cancer cells. We first transfected vectors carrying CUL4A and specific shCUL4A into breast cancer cells and corresponding Adr cells respectively. Using reverse transcription polymerase chain OPEN ACCESSMolecules 2014, 19 160 reactions and western blots, we found that overexpression of CUL4A in MCF7 and MDA-MB-468 cells up-regulated MDR1/P-gp expression on both the transcription and protein levels, which conferred multidrug resistance to P-gp substrate drugs, as determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. On the other hand, silencing CUL4A in MCF7/Adr and MDA-MB-468/Adr cells led to the opposite effect. Moreover, ERK1/2 in CUL4A-overexpressing cells was highly activated and after treatment with PD98059, an ERK1/2-specific inhibitor, CUL4A-induced expression of MDR1/P-gp was decreased significantly. Lastly, immunohistochemistry in breast cancer tissues showed that P-gp expression had a positive correlation with the expression of CUL4A and ERK1/2. Thus, these results implied that CUL4A and ERK1/2 participated in multi-drug resistance in breast cancer through regulation of MDR1/P-gp expression.

TRIM16 suppresses the progression of prostate tumors by inhibiting the Snail signaling pathway

“…The generation of retrovirus supernatants and the transfection of cells were conducted as described in a previous study (18). Infected cells were selected by the addition of 2 μg/ml puromycin (Sigma, St. Louis, MO, USA) to the culture medium for 48 h and then maintained in complete medium with 1 μg/ml puromycin.…”

Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21

“…Histone H3K27 methyltransferase, EZH2, and H3K4 demethylases LSD1 and KDM5B have been thought to play important roles not only in tumor initiation, but also in tumor progression, since overexpression of these genes has been reported in many types of malignant tumors [30]. Previous papers revealed that upregulation of KDM5B enhanced cell migration, cell invasion and EMT to promote malignant progression of lung cancer cells [32,33]. However, the role of KDM5B in glioma carcinogenesis remains unclear.…”

Ubiquitin-specific protease 28 is overexpressed in human glioblastomas and contributes to glioma tumorigenicity by regulating MYC expression

“…20,21 Genetic studies have shown that c-MYC proto-oncogene encodes a transcription factor, MYC, which is a central regulator of cell growth, proliferation, and apoptosis. 13,12 Enhanced levels of MYC are thought to contribute to the formation of many human tumors.…”